Zomedica Corp (ZOM)
0.133
0.00 (0.00%)
USD |
NYAM |
Apr 26, 12:34
Zomedica Research and Development Expense (Quarterly): 3.099M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.099M |
| September 30, 2023 | 0.867M |
| June 30, 2023 | 0.859M |
| March 31, 2023 | 0.918M |
| December 31, 2022 | 0.693M |
| September 30, 2022 | 1.215M |
| June 30, 2022 | 0.319M |
| March 31, 2022 | 0.351M |
| December 31, 2021 | 0.665M |
| September 30, 2021 | 0.289M |
| June 30, 2021 | 0.271M |
| March 31, 2021 | 0.412M |
| December 31, 2020 | 0.8382M |
| September 30, 2020 | 2.702M |
| June 30, 2020 | 3.908M |
| March 31, 2020 | 0.6301M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.7899M |
| September 30, 2019 | 0.9625M |
| June 30, 2019 | 1.062M |
| March 31, 2019 | 7.531M |
| December 31, 2018 | 6.552M |
| September 30, 2018 | 0.6304M |
| June 30, 2018 | 2.535M |
| March 31, 2018 | 0.6003M |
| December 31, 2017 | 1.165M |
| September 30, 2017 | 0.4655M |
| June 30, 2017 | 0.5042M |
| March 31, 2017 | 0.6164M |
| December 31, 2016 | 0.5776M |
| September 30, 2016 | 0.4111M |
| June 30, 2016 | 0.3082M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.271M
Minimum
Jun 2021
3.908M
Maximum
Jun 2020
1.097M
Average
0.8382M
Median
Dec 2020
Research and Development Expense (Quarterly) Benchmarks
| Ainos Inc | 2.237M |
| OpGen Inc | 1.202M |
| LENSAR Inc | 1.463M |
| Eargo Inc (DELISTED) | 4.742M |
| Intelligent Bio Solutions Inc | 0.3485M |